SEMAGLUTIDE : ONE THOROUGH REVIEW

The novel class of GLP-1 receptor agonist and GIP combined medications, including tirzepatide, semaglutide, and the recently introduced retatrutide, represent significant improvements in metabolic control. Although all three work by influencing blood concentrations, they vary in their unique mech